ASTRAZEN — Astrazeneca Pharma India Share News
0.000.00%
Last trade - 00:00- IN₹210.84bn
- IN₹207.37bn
- IN₹22.76bn
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication
Brief: Astrazeneca Pharma India Dec-Quarter PAT 325.9 Million Rupees
Brief: Astrazeneca Pharma India Ltd Receives Permission To Import Durvalumab
Brief: Astrazeneca Pharma India Receives Permission To Import Datopotamab Deruxtecan Powder To India
Brief: Astrazeneca Pharma India Gets Tax Order With Estimated Tax Impact Of 33 Million Rupees
Brief: Astrazeneca Pharma India And Sun Pharma Partner For Hyperkalaemia Treatment
Brief: Astrazeneca Pharma India Sept-Quarter PAT 542.2 Million Rupees
Receives Permission To Import Enhertu
Brief: Astrazeneca Pharma India Gets Show Cause Notice From National Pharmaceutical Pricing Authority
Brief: Astrazeneca Pharma India Surrenders Manufacturing License
AstraZeneca Pharma India gains on quarterly profit
Brief: Astrazeneca Pharma India June-Quarter PAT 558.3 Million Rupees
Brief: Astrazeneca Pharma India Received Permission To Import Durvalumab Solution In India
Brief: Astrazeneca Says Co Expands Bangalore Global Hub In India With 1.66 Billion Rupees Investment
Brief: Astrazeneca Pharma India Says Sanjeev Kumar Panchal Has Offered To Resign As MD
India's AstraZeneca Pharma jumps over 11% on Q4 profit jump